| __timestamp | Summit Therapeutics Inc. | Takeda Pharmaceutical Company Limited |
|---|---|---|
| Wednesday, January 1, 2014 | 15635076 | 382096000000 |
| Thursday, January 1, 2015 | 23943601 | 345927000000 |
| Friday, January 1, 2016 | 23689111 | 312303000000 |
| Sunday, January 1, 2017 | 41006114 | 325441000000 |
| Monday, January 1, 2018 | 51379106 | 368298000000 |
| Tuesday, January 1, 2019 | 32705593 | 492381000000 |
| Wednesday, January 1, 2020 | 53274000 | 455833000000 |
| Friday, January 1, 2021 | 85352000 | 526087000000 |
| Saturday, January 1, 2022 | 51999000 | 633325000000 |
| Sunday, January 1, 2023 | 59471000 | 729924000000 |
| Monday, January 1, 2024 | 729924000000 |
Unlocking the unknown
In the ever-evolving pharmaceutical industry, research and development (R&D) spending is a key indicator of a company's commitment to innovation. Over the past decade, Takeda Pharmaceutical Company Limited has consistently outpaced Summit Therapeutics Inc. in R&D investment. From 2014 to 2023, Takeda's R&D expenses have surged by approximately 91%, reaching a staggering $730 billion in 2023. In contrast, Summit's R&D spending, while growing, remains modest, peaking at around $59 million in 2023. This disparity highlights Takeda's robust focus on innovation, investing nearly 12,000 times more than Summit in 2023 alone. Such financial commitment underscores Takeda's strategic priority to lead in pharmaceutical advancements. However, Summit's steady increase in R&D spending, despite its smaller scale, reflects its dedication to growth and innovation in niche areas. Missing data for 2024 suggests ongoing developments, leaving room for future insights.
Research and Development Expenses Breakdown: Regeneron Pharmaceuticals, Inc. vs Summit Therapeutics Inc.
Who Prioritizes Innovation? R&D Spending Compared for Takeda Pharmaceutical Company Limited and CymaBay Therapeutics, Inc.
Analyzing R&D Budgets: Takeda Pharmaceutical Company Limited vs Amicus Therapeutics, Inc.
Who Prioritizes Innovation? R&D Spending Compared for Takeda Pharmaceutical Company Limited and Soleno Therapeutics, Inc.
Comparing Innovation Spending: Takeda Pharmaceutical Company Limited and MannKind Corporation
Who Prioritizes Innovation? R&D Spending Compared for Takeda Pharmaceutical Company Limited and Travere Therapeutics, Inc.
Takeda Pharmaceutical Company Limited or Viridian Therapeutics, Inc.: Who Invests More in Innovation?
Comparing Innovation Spending: Summit Therapeutics Inc. and Madrigal Pharmaceuticals, Inc.
Analyzing R&D Budgets: Summit Therapeutics Inc. vs Axsome Therapeutics, Inc.
Research and Development: Comparing Key Metrics for Summit Therapeutics Inc. and Rhythm Pharmaceuticals, Inc.
R&D Insights: How Summit Therapeutics Inc. and PTC Therapeutics, Inc. Allocate Funds
Research and Development: Comparing Key Metrics for Summit Therapeutics Inc. and Travere Therapeutics, Inc.